Integration gains offset by margin collapse, RIECO drag persists
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Q1 beat sparked no guidance lift; Q2 weakness forced defensive reaffirmation. RIECO integration delays and cost overruns hint at execution friction.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Sudarshan is mid-integration with strong legacy-business momentum (H1 +22% revenue, 15.6% EBITDA) but severe near-term headwinds: Q2 PAT collapsed -70.5% QoQ to 1.1% NPM, RIECO acquisition dragging (negative EBITDA), and macro uncertainty (US housing, European construction weak). Management reaffirmed EUR 700M/EUR 35M EBITDA guidance defensively but credibility is mixed given operational challenges. Long-term 7× EBITDA target is ambitious but lacks near-term de-rating risk.
₹2742.6 Cr
Revenue · +14.9% YoY₹30.5 Cr
Reported PAT · +58% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
H1 Legacy business revenue grew 22%, EBITDA 36.5%
METH1 FY27 Legacy: INR 1,636 Cr (22% YoY), EBITDA INR 243 Cr (36.5% YoY growth) — supported
EBITDA 15.6% margin H1 at Legacy level
METINR 243 Cr EBITDA / ~INR 1,551 Cr revenue = 15.7% — accurate
Acquired Group consistent performance, strong value capture underway
OVERSTATEDAcquired Group H1 INR 3,935 Cr revenue, 6.1% EBITDA margin but RIECO negative (INR -3 Cr EBITDA Q2) — partially contradicted
Total pigment global business showing healthy EBITDA: INR 242 Cr
MISSINR 242 Cr EBITDA / INR 2,695 Cr revenue = 9% margin, down from INR 327 Cr (prior) — margin declining, contradicts health narrative
Q2 FY27 delivered strong growth; external challenges being navigated
OVERSTATEDRevenue +14.9% YoY but PAT +58% YoY masks -70.5% QoQ PAT collapse (30.5 Cr); NPM 1.1% signals severe margin compression — overstated
Earnings quality
What changed since the last call
RIECO integration hitting headwinds
DowngradeQ1 showed 6.1% EBITDA margin; Q2 RIECO negative. Supply chain, execution delays cited. Cost synergies lagging vs. guidance assumptions.
Guidance stance: defensive reaffirmation
NeutralEUR 700M/EUR 35M EBITDA 'reaffirmed, no revision' despite Q1 beat and Q2 challenges. Phrasing signals caution, not confidence in upside.
VP4 divestiture closure (post-quarter)
NewEUR 75.8M non-core asset sale for debt reduction. Not included in Q2 results; signals balance-sheet focus over growth capex.
Customer trust recovery in progress
UpgradeManagement claims lost market share from Heubach insolvency being regained; destocking scenario ongoing but expected to ease.
The Q&A
Analysts pressed hard on cost synergies (Q1 guidance implied 12% EBITDA margin, Q2 delivered ~9%) and inventory docking. Management partially dodged specific cost-reduction numbers, cited integration work in progress, defended guidance as conservative. Tone: analytical pressure but not hostile; management held line on guidance.
Revenue growth drivers — Nitesh Dhoot, Nomura
AnsweredAbout half-and-half price vs. volume. Some volume growth in Acquired Group but muted. Lost sales across industries being regained; process underway but will take time.
EBITDA margin bridge — Nitesh Dhoot, Nomura
PartialVP4 sale factored out; this is first normal two, three quarter. Keeping guidance because it is experience with this business. External situation very challenging, geopolitical uncertainties.
Heubach EBITDA improvement levers — Niharika
AnsweredTwo aspects: strong value capture in operations, purchase-org structure. Using backward integration, AI leverage, cost synergies. Inventory destocking from customers ongoing but expected over, not forever.
VP4 deal and cash deployment — Viraj Mahadevia, Jefferies
DodgedBoard looking at all options. Transformation completed; now looking at how to use cash for better shareholder returns. No immediate plans but will decide in a year's time.
Cost synergy realization timeline — Rohit, Goldman Sachs
PartialAbsolutely. Manufacturing and procurement work underway. Backward integration, AI still leveraging. 300-400 basis points swing on margins with backward integration and AI implementation possible. Should bridge margin.
Acquired Group EUR 35M EBITDA feasibility — Arch Verma, DAM Capital
AnsweredManufacturing cost reduction, procurement, yield improvements across sites. IT integration with backward-integration projects ongoing; second use of AI still leveraging. Scope for 300 bps swing on margins. Backward integration not done; can win some volumes.
Guidance
FY27 Acquired Group EUR 700M turnover (reaffirmed)
MediumGuidance unchanged from prior call; macro caution cited (US housing, European construction weak). No upside lift despite Q1 beat.
Long-term: 7× 2023 EBITDA by FY29 (~₹1,400+ Cr total EBITDA)
MediumMechanism: cost synergies (manufacturing, procurement, backward integration, SAP, AI), value capture, market-share recovery. Timeline FY29; credibility hinges on RIECO turnaround and macro stabilization.
300-400 basis points margin swing possible from backward integration, AI, cost reduction
LowManagement cited this in Q&A but offered no timeline. Current total pigment EBITDA margin 9%; targeting 12-13% implied by 7× EBITDA guidance, but no explicit margin target stated.
EUR 35M Acquired Group EBITDA (reaffirmed, 5% of EUR 700M revenue)
LowRIECO Q2 negative EBITDA, supply-chain issues, integration delays undermine confidence. Reaffirmation appears defensive, not based on updated assumptions.
Risks the call surfaced
Execution risk (integration)
HighSAP integration only 2 of 130 applications live; backward-integration projects not fully commercialized yet. RIECO negative EBITDA Q2 signals slow progress on synergies. Cost reduction targets (300-400 bps margin swing) dependent on completion.
Macro headwinds (demand weakness)
HighManagement explicitly cited US housing and European construction as weak. Masterbatch demand volatile due to oil prices. Customer destocking ongoing (demand 'mute'). These segments represent majority of Acquired Group revenue.
Guidance credibility (EUR 35M EBITDA)
HighEUR 35M EBITDA target for Acquired Group (5% margin on EUR 700M) looks stretched given RIECO negative Q2 and Q2 total pigment EBITDA margin only 9% despite integration benefits claimed. Reaffirmation described as defensive ('cautiously navigating'), not based on updated numbers.
Q2 profitability cliff
HighPAT collapsed to ₹30.5 Cr (1.1% NPM) despite +14.9% YoY revenue growth and positive EBITDA momentum. Project cost overruns cited but unquantified. Unclear if one-time or structural; suggests operational distress not reflected in forward guidance.
Market-share recovery pace (Heubach legacy)
MediumDuring Heubach insolvency, Sudarshan lost significant market share and customer trust. Management claims recovery 'underway' but timeline vague ('some time to build that up'). Regaining depends on operational stability and cost competitiveness, both still unproven.
Management
Score 7/10. Clear on structure and progress (integration, SAP, backward integration), but evasive on specific cost numbers and PAT collapse detail. Transparent on challenges (macro, RIECO, destocking) but defensive on guidance credibility. Mixed. H1 Legacy business +22% revenue, +36.5% EBITDA growth demonstrates strong standalone execution. But Acquired Group integration hits headwinds: RIECO negative Q2, SAP 2/130 live, cost synergies lagging (9% margin vs. expected 12%+). Q2 PAT -70.5% QoQ unexplained fully.
1 · Q3 FY27 (Oct-Dec 2026)
Macro stabilization in US/Europe; customer destocking resolution
2 · FY27-end (Mar 2027)
RIECO turnaround visible; SAP integration phases 1 & 2 complete
3 · FY28-FY29
7× 2023 EBITDA trajectory; backward-integration projects yielding cost leverage
Long-term 7× EBITDA target is ambitious but lacks near-term de-rating risk.
Informational and educational content only. Not investment advice.